A case of levetiracetam induced bullous pemphigoid

Karadag A. S., Güneş Bilgili S., Calka O., Onder S., Kosem M., Burakgazi-Dalkilic E.

CUTANEOUS AND OCULAR TOXICOLOGY, cilt.32, sa.2, ss.176-178, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.3109/15569527.2012.725444
  • Dergi Adı: CUTANEOUS AND OCULAR TOXICOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.176-178
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Bullous pemphigoid is a chronic, acquired autoimmune skin disease. Certain drugs such as furosemide, penicillins, sulfonamides, ciprofloxacins, penicillamines, angiotensin converting enzyme inhibitors, chloroquine, and phenacetin were reported to cause bullous pemphigoid. This is a case report of a 70-year-old female, who presented with the formation of diffuse cutaneous blister in month after starting to use levetiracetam. Dermatological exam and histopathological findings were consistent with bullous pemphigoid. To the best of our knowledge this is the first case of bullous pemphigoid in the literature associated with levetiracetam use.